How Many Units Is 5mg of Tirzepatide?

Each 5mg Mounjaro KwikPen holds 3ml of solution at a concentration of 5mg/3ml, equivalent to 80 units across four weekly 20-unit doses.
The pen is pre-set: no drawing up, no measuring, no syringe required, each press delivers the full 5mg weekly dose automatically.
5mg is the second strength in the tirzepatide schedule, typically reached after four weeks on the 2.5mg starter pen.
The unit count matters mainly if you are transitioning to or from a vial-based product; the KwikPen removes that calculation entirely.

The 5mg Mounjaro KwikPen contains 80 units of tirzepatide in total — four weekly doses of 20 units each — at a concentration of 1mg per 4 units. That single pen covers one full month of treatment. Because the pen is pre-filled and pre-set, you never draw a dose yourself; the device delivers exactly 20 units (5mg) each week when the plunger is pressed fully. These are prescription-only medicines assessed individually by a clinician before they can be supplied, so the right dose for you is always a prescriber's call rather than a self-calculation.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Units, concentrations and what they mean for your 5mg pen

What does '20 units' actually mean in a pre-filled pen?

Tirzepatide's concentration in the Mounjaro KwikPen is standardised across all strengths at a ratio that sets 1mg equal to 4 units. At 5mg, that works out to 20 units per weekly dose. The full pen (three millilitres of solution) therefore contains 80 units in total, split into four equal doses.

This unit language comes from insulin practice, where syringes are calibrated in units rather than milligrams. If a patient, carer or healthcare professional ever cross-references the volume against a unit count, that 4-units-per-mg ratio is the conversion to use. For anyone moving from a vial-and-syringe protocol to the KwikPen, the arithmetic is the same; only the delivery method changes.

In day-to-day use, though, the figure is largely academic. The KwikPen does not have a dial you set to 20; it has a single plunger that, pressed firmly until it clicks and then held for ten seconds at the injection site, releases the entire 5mg dose. Our 5mg Mounjaro page covers the practical steps in more detail. The SmPC on the electronic Medicines Compendium is the authoritative reference for concentration and volume data if you need them for clinical documentation.

Why does the 5mg pen come after 2.5mg, and does that change the unit count?

The starting pen in the tirzepatide schedule is 2.5mg. That pen delivers 10 units per weekly injection, again at the same 4-units-per-mg ratio. Moving to 5mg at week five doubles the weekly unit count to 20, but the mechanical experience is identical: one press of the plunger, one dose.

The escalation exists because tolerability matters more than speed. The body adjusts to GLP-1 and GIP receptor activity gradually, and stepping up through the schedule reduces the chance of significant nausea or GI discomfort. The 2.5mg pen's unit breakdown follows the same logic at half the dose. Higher strengths (7.5mg, 10mg, 12.5mg and 15mg) all use pens calibrated identically, so a 7.5mg dose is 30 units, and so on up the schedule.

Prescribers decide whether and when to increase the dose. The NHS page on tirzepatide explains the general titration approach clearly. What matters from your side is keeping to the once-weekly rhythm and storing the pen correctly, it lives in the fridge (2–8°C), and the door shelf works well as long as the temperature stays stable.

Can I convert unit counts across different tirzepatide strengths myself?

The maths is consistent (1mg equals 4 units throughout the Mounjaro range) so the arithmetic is simple enough. A 10-unit dose is 2.5mg; 30 units is 7.5mg; 60 units is 15mg. These conversions are useful context, particularly for patients who want to understand what they have been prescribed relative to other strengths.

What the conversion cannot tell you is whether a different dose is right for you. Tirzepatide is a prescription-only medicine and the NICE appraisal of tirzepatide (TA1026) makes clear that dose decisions sit with the prescribing clinician, accounting for weight loss response, tolerability and individual health history. Self-adjusting outside the agreed schedule is not recommended.

If you are researching costs alongside dosing, the Mounjaro cost page gives an honest account of how UK private pricing works by strength. For a broader look at where tirzepatide fits among available treatments, the weight-loss treatments overview is a useful starting point.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions